Early recurrence of neurocysticercosis after orthotopic liver transplant.
Department of Hepatology, Addenbrooke's Hospital, Cambridge, United Kingdom.
Matthew
M
Hoare
William T H
WT
Gelson
Nagui
N
Antoun
Graeme J M
GJ
Alexander
D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D002540:Cerebral Cortex; D005500:Follow-Up Studies; D005682:Gadolinium; D006085:Graft Survival; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000175:diagnosis / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D008279:Magnetic Resonance Imaging; D008297:Male; D020019:Neurocysticercosis / Q000175:diagnosis* / Q000188:drug therapy; D011183:Postoperative Complications / Q000175:diagnosis*; D011300:Preoperative Care; D012008:Recurrence; D018570:Risk Assessment; D012720:Severity of Illness Index; D014184:Transplantation, Homologous
D005682:Gadolinium; D015766:Albendazole